NURECA
|
|
BOM : 543264     NSE : NURECA     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : NA |
Dec 30,2024 |
Price(EOD): ₹ 282.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Medical Equipment/Supplies/Accessories |
MCap: ₹ 282.15 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
NURECA | 1.2% | -0.4% | -37.5% |
POLY MEDICURE | 6.6% | -2.4% | 75.3% |
PREVEST DENPRO | 1.2% | -1% | 40.7% |
FUNDAMENTAL ANALYSIS OF NURECA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF NURECA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-100.73
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -2.80 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] 1.46
P/B Calculated based on Book Value of Rs 193.11 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.11
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 90.80 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
3948% 17% 16% |
SHARE PRICE MOMENTUM OF NURECA
NURECA vs SENSEX
DEBT OF NURECA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0.01 - |
0 0 0 - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF NURECA
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF NURECA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
53.88% 0.51% -102.86% -129% |
-0.52% -270.18% -101.92% -116.66% |
QtrlyTrend |
-4 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
NURECA related INDICES
You may also like the below Video Courses
FAQ about NURECA
Is NURECA good for long term investment?
As on Dec 30,2024, the Fundamentals of NURECA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NURECA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is NURECA UnderValued or OverValued?
As on Dec 30,2024, NURECA is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of NURECA ?
As on Dec 30,2024, the Intrinsic Value of NURECA is Rs. 240.44 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 6.97
Fair Value [Median EV / Sales Model] : Rs. 240.44
Fair Value [Median Price / Sales Model] : Rs. 242.42
Estimated Median Fair Value of NURECA : Rs. 240.44
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.